BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20818339)

  • 1. MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas.
    Tömböl Z; Eder K; Kovács A; Szabó PM; Kulka J; Likó I; Zalatnai A; Rácz G; Tóth M; Patócs A; Falus A; Rácz K; Igaz P
    Mod Pathol; 2010 Dec; 23(12):1583-95. PubMed ID: 20818339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome.
    Eisenhofer G; Huynh TT; Pacak K; Brouwers FM; Walther MM; Linehan WM; Munson PJ; Mannelli M; Goldstein DS; Elkahloun AG
    Endocr Relat Cancer; 2004 Dec; 11(4):897-911. PubMed ID: 15613462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
    Vogel TW; Brouwers FM; Lubensky IA; Vortmeyer AO; Weil RJ; Walther MM; Oldfield EH; Linehan WM; Pacak K; Zhuang Z
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3747-51. PubMed ID: 15769989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
    Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
    Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
    N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma.
    Walther MM; Reiter R; Keiser HR; Choyke PL; Venzon D; Hurley K; Gnarra JR; Reynolds JC; Glenn GM; Zbar B; Linehan WM
    J Urol; 1999 Sep; 162(3 Pt 1):659-64. PubMed ID: 10458336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
    Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
    Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How many pathways to pheochromocytoma?
    Neumann HP; Hoegerle S; Manz T; Brenner K; Iliopoulos O
    Semin Nephrol; 2002 Mar; 22(2):89-99. PubMed ID: 11891502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Array-comparative genomic hybridization in sporadic benign pheochromocytomas.
    van Nederveen FH; Korpershoek E; deLeeuw RJ; Verhofstad AA; Lenders JW; Dinjens WN; Lam WL; de Krijger RR
    Endocr Relat Cancer; 2009 Jun; 16(2):505-13. PubMed ID: 19153209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
    Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma.
    Patterson E; Webb R; Weisbrod A; Bian B; He M; Zhang L; Holloway AK; Krishna R; Nilubol N; Pacak K; Kebebew E
    Endocr Relat Cancer; 2012 Apr; 19(2):157-66. PubMed ID: 22241719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma.
    Zeiger MA; Zbar B; Keiser H; Linehan WM; Gnarra JR
    Genes Chromosomes Cancer; 1995 Jul; 13(3):151-6. PubMed ID: 7669733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of phenylethanolamine N-methyltransferase in pheochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
    Huynh TT; Pacak K; Wong DL; Linehan WM; Goldstein DS; Elkahloun AG; Munson PJ; Eisenhofer G
    Ann N Y Acad Sci; 2006 Aug; 1073():241-52. PubMed ID: 17102092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.
    Dannenberg H; Komminoth P; Dinjens WN; Speel EJ; de Krijger RR
    Endocr Pathol; 2003; 14(4):329-50. PubMed ID: 14739490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pheochromocytomas in Nf1 knockout mice express a neural progenitor gene expression profile.
    Powers JF; Evinger MJ; Zhi J; Picard KL; Tischler AS
    Neuroscience; 2007 Jul; 147(4):928-37. PubMed ID: 17582688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial pheochromocytomas and paragangliomas: stories from the sign-out room.
    Perren A; Komminoth P
    Endocr Pathol; 2006; 17(4):337-44. PubMed ID: 17525482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2.
    Koch CA; Mauro D; Walther MM; Linehan WM; Vortmeyer AO; Jaffe R; Pacak K; Chrousos GP; Zhuang Z; Lubensky IA
    Endocr Pathol; 2002; 13(1):17-27. PubMed ID: 12114747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.
    Benn DE; Dwight T; Richardson AL; Delbridge L; Bambach CP; Stowasser M; Gordon RD; Marsh DJ; Robinson BG
    Cancer Res; 2000 Dec; 60(24):7048-51. PubMed ID: 11156410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA 183 family profiles in pheochromocytomas are related to clinical parameters and SDHB expression.
    Pillai S; Lo CY; Liew V; Lalloz M; Smith RA; Gopalan V; Lam AK
    Hum Pathol; 2017 Jun; 64():91-97. PubMed ID: 28412207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.